Synthesis and evaluation of imidazolidinones as nonpeptide HIV-protease inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 5, 1997, Pages 495-500

  De Lucca, George V ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAZOLIDINE DERIVATIVE; PROTEINASE INHIBITOR;

ARTICLE; COMPUTER MODEL; DRUG DESIGN; DRUG SYNTHESIS; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; X RAY ANALYSIS;

EID: 0031552149     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00006-1     Document Type: Article

References (16)

1. 1. For a recent review see: De Clercq, E. J. Med. Chem. 1995, 38, 2491.
2. 2. Kohl, N. E.; Emini, E. A.; Schleif, W. A.; Davis, L. J.; Heimbach, J. C.; Dixon, R. A. F.; Scolnick, E. M. and Sigal, I.S. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 4686.
3. 3. (a) Wei, X.; Ghosh, S. K.; Taylor, M. E.; Johnson, V. A.; Emini, E. A.; Deutsch, P.; Lifson, J. D.; Bonhoeffer, S.; Nowak, M. A.; Hahn, B. H.; Saag, M. S. and Shaw, G. M. Nature. 1995, 373, 117-122.
4. (b) Ho, D. D.; Neumann, A. U.; Perelson, A. S.; Chen, W.; Leonard, J. M.; Markowitz, M. Nature 1995, 373, 123.
5. (c) Kitchen, V. S.; Skinner, C.; Ariyoshi, K.; Lane, E. A.; Duncan, I. B.; Burckhardt, J.; Burger, H. U.; Bragman, K.; Pinching, A. J.; Weber, J. N. The Lancet 1995, 345, 952.
6. 4. Lam, P. Y. S.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; Bacheler, L. T.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, N. Y.; Chang, C-H.; Weber, P. C.; Jackson, D. A.; Sharpe, T. R.; Erickson-Viitanen, S. Science 1994, 263, 380.
7. 5. (a) Lam, P. Y. S.; Ru, Y.; Jadhav, P. K.; Aldrich, P. E.; De Lucca, G. V.; Eyermann, C. J.; Chang, C-H.; Emmett, G.; Holler, E. R.; Daneker, W. F.; Li, L.; Confalone, P. N.; McHugh, R. J.; Han, Q.; Markwalder, J. A.; Seitz, S. P.; Bacheler, L. T.; Rayner, M. M.; Klabe, R. M.; Shum, L.; Winslow, D. L.; Kornhauser, D. M.; Jackson, D .A.; Erickson-Viitanen, S.; Sharpe, T. R.; Hodge, C. N. J. Med. Chem. 1996, 39, 3514.
8. (b) Wong, Y. N.; Burcham, D. L.; Saxten, P. L.; Erickson-Viitanen, S.; Grubb, M. F.; Quon, C. Y.; Huang, S-M. Biopharm. Drug. Dispos. 1994, 15, 535.
9. 6. Hodge, C. N.; Aldrich, P. E.; Bacheler, L. T.; Chang, C-H.; Eyermann, C. J.; Garber, S.; Grubb, M.; Jackson, D. A.; Jadhav, P. K.; Korant, B.; Lam, P. Y. S.; Maurin, M. B.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Reid, C.; Sharpe, T. R.; Shúm, L.; Winslow, D. L.; Erickson-Viitanen, S. Chemistry and Biology 1996, 3, 301.
10. 7. (a) De Lucca, G. V.; Lam, P. Y. S.; Chang, C-H.; Meek, J.; Rayner, M.; Erickson-Viitanen, S. Presented at the 209th National Meeting of the American Chemical Society, Anaheim, CA, April 1995, Div. of Med. Chem., No. 004.
11. (b) De Lucca, G. V.; Calabrese, J.; Liang, J.; Lam, P. Y. S.; Chang, C-H.; Meek, J.; Rayner, M.; Erickson-Viitanen, S. Presented at the 1995 International Chemical Congress of Pacific Basin Societies, December 17-22, 1995, Org. Chem. No. 631.
12. (c) De Lucca, G. V.; Calabrese, J.; Meek, J.; Rayner, M. Presented at the 209th ACS National Meeting, Anaheim, CA, April 1995, Division of Org. Chem., No. 514.
13. 8. A literature search produced only one example of a similar rearrangement: Berges, D. A.; Schmidt, S. J. J. Org. Chem. 1984, 49, 4555.
14. 9. Barton, D.H.R.; McCombie, S.W. J. Chem. Soc. Perkin Trans. 1, 1975, 1574.
15. 10. We thank Dr. J. Calabrese (CRD&D Dupont Co.) for X-ray analysis of 9.
16. i's were measured by Mr. R. Klabe as described previously in: Erickson-Viitanen, S.; Klabe, R. M.; Cadwood, P. G.; O'Neal, P. L.; Meek, J. L. Antimicrob. Agents Chemother. 1994, 38, 1628.